Overview

Safety and Efficacy Study of a Eye Drop for Eye Allergy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy eyedrop.
Phase:
Phase 3
Details
Lead Sponsor:
Vistakon Pharmaceuticals
Treatments:
Alcaftadine
Ophthalmic Solutions